INSIGHTS ON FACILITY DESIGN
-
The Environmental Case For Single-Use Systems
Discover how life-cycle assessments reveal the hidden resource and energy burdens of equipment cleaning versus single-use systems in modern pharmaceutical production facilities.
-
Operation Readiness Strategy To Improve Project Delivery And Startup Success
A therapy won approval, and the site celebrated, until the CFO reported the cost of goods at three times the target. With budget and schedule both met, what had the project itself failed to measure?
-
Why Bridging Cleanroom Infrastructure And Process Equipment Design Is Critical
Conflicting regulations and poor design can misalign cleanroom mechanical systems with process equipment, creating contamination risks, compromising product quality, and delaying facility startup.
-
Designing A Single-Use ADC Production Suite
Dedicated antibody-drug conjugate production inside a fixed footprint and timeline depends on single-use workflow design that balances conjugation flexibility, primary containment, and fluid management.
-
Rethinking Facility Design For The Reality Of Complex Biologics11/4/2026
Inert surface technologies reduce metal-related adsorption in chromatography, improving peak shape, recovery, sensitivity, and quantitation for more reliable analytical results.
-
Advances In ADC Development And Manufacturing11/3/2026
ADC manufacturability starts at molecule design, not downstream rescue. Learn how operator exposure to high-potency payloads shapes how conjugation workflows are built and qualified.
-
The Body As A Bioreactor – The Execution10/31/2026
Genomic medicine depends as much on infrastructure as on the therapies themselves. Distributed production, scalable processes, and evolving regulation shape whether these medicines reach patients.
-
All You Need To Know About GMP Manufacturing Of mRNA-LNP Drug Products10/13/2026
Moving mRNA-LNP production from lab to GMP scale exposes tensions among formulation consistency, regulatory expectations, and facility safety, while automation offers ways to resolve them.
-
Building A Flexible Vaccine Manufacturing Facility With Tonix Pharmaceuticals' Siobhan Fogarty10/6/2026
In this episode of "Better Biopharma," host Tyler Menichiello is joined by Tonix Pharmaceuticals' chief technical officer, Siobhan Fogarty, to discuss the planning and construction of its manufacturing facility in Dartmouth, MA, which was purpose-built for the production of its horsepox-based live viral vaccine platform, TNX-801.
FACILITY DESIGN SOLUTIONS
-
Unused 4,790 gallon Paget Equipment receiver tank, 304 stainless steel construction, approximately 8'6" diameter x 9' straight side, dish top and bottom, rated 15 psi at 250 f internal, side lug mounted, serial# 06-443, built 2007.
-
Unused 4,790 gallon Pagent Equipment receiver tank, 304L stainless steel construction, approximately 8'6" diameter x 9' straight side, dish top and bottom, rated 15 psi at 250 f internal, on legs, serial# 06-450, national board# 22299, built 2007.
-
Unused 23,000 gallon Pagent Equipment receiver tank, 304L stainless steel construction, approximately 144" diameter x 24' straight side, dish top and bottom, rated 15 psi at 250 f internal, serial# 06-461, national board# 22547, built 2007.
-
Unused 12,700 gallon Pagent Equipment receiver tank, 316L stainless steel construction, approximately 12' diameter x 11'8" straight side, dish top and bottom, rated 15 psi at 250 f internal, serial# 06-452, national board# 22692, built 2007.
-
Unused Sartorius Pro Mixer Drive unit for Sartorius Palletanks, built 2022.